IKS Santé, a Dallas-based company specializing in healthcare software solutions, has announced its acquisition of ARAI this week. This strategic move aims to enhance IKS’s agentic AI infrastructure while decreasing its reliance on third-party AI models. The financial details of the transaction remain undisclosed.
Through this acquisition, IKS gains access to ARAI’s biomedical knowledge graphs and ontological layer. This technology organizes complex medical terminology and relationships in a format easily interpretable by AI systems, according to Ajai Sehgal, Chief AI Officer of IKS.
Sehgal noted that ARAI provides IKS with a substantial and organized corpus of medical knowledge, which the company would have taken years to develop independently. By ensuring that AI systems better understand medical terminology and coding frameworks, IKS aims to enhance the precision and efficiency of its tools.
He highlighted that the integration of knowledge graphs is expected to significantly reduce costs associated with large language models (LLMs). Rather than inundating an LLM with vast amounts of medical terminology and context for every task, IKS can now leverage graph traversal to refine context from the outset.
For instance, if a clinical note pertains to dermatology, the IKS system will fetch only dermatology-specific ontologies before processing the relevant information through the model, explained Sehgal.
“What this actually does is significantly reduce our costs associated with utilizing large language models,” he stated. “By optimizing our costs, we also lower expenses for our clients, leading to greater profitability: spend less, earn more. When I mention cost reduction, it’s substantial—between 80 to 90 percent.”
The acquisition bolsters several ongoing AI automation initiatives at IKS, including coding, revenue cycle management, and tracking. The firm envisions that knowledge graphs will serve as a foundational infrastructure supporting multiple IKS products.
Sehgal emphasized that IKS is transitioning from a labor-intensive service provider to an AI-driven technology platform. This acquisition will facilitate a shift away from manual processes toward automated workflows, where human oversight will guide outcomes rather than handle the majority of tasks.
He articulated that this acquisition is significant for both technology and talent. The founders of ARAI bring extensive expertise in healthcare AI, and their academic connections in India create a pipeline for recruiting elite AI talent in the future.
In the fast-moving landscape of AI, speed to market is a crucial competitive advantage, Sehgal remarked. He argued that organically developing AI expertise is too slow, prompting IKS to focus on acquiring specialized teams that can contribute to its competitiveness in a rapidly evolving market.
The company has previously acquired AQuity and Robin Healthcare in recent years—transactions that allowed IKS to quickly gain targeted capabilities and specialized talent, according to Sehgal.
“This decision aligns seamlessly with IKS’s historical acquisition strategy, and we will continue to pursue such acquisitions to secure the best talent as needed,” he concluded.
Photo: Witthaya Prasongsin, Getty Images
